Dr Reddys (Germany) Top Insiders

RDDA Stock  EUR 12.00  0.20  1.64%   
Dr Reddys employs about 24.8 K people. The company is managed by 7 executives with a total tenure of roughly 57855 years, averaging almost 8265.0 years of service per executive, having 3542.14 employees per reported executive. Examination of Dr Reddys' management performance can provide insight into the company performance.
Parag Agarwal  Insider
CFO Council
Sanjay BTech  Insider
Global VP
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Dr Reddys Management Team Effectiveness

The company has return on total asset (ROA) of 0.0949 % which means that it generated a profit of $0.0949 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1772 %, meaning that it generated $0.1772 on every $100 dollars invested by stockholders. Dr Reddys' management efficiency ratios could be used to measure how well Dr Reddys manages its routine affairs as well as how well it operates its assets and liabilities.
100%

Dr Reddys Workforce Comparison

Dr Reddys Laboratories is currently regarded as top stock in number of employees category among its peers. The total workforce of Drug Manufacturers - Specialty & Generic industry is at this time estimated at about 80,616. Dr Reddys totals roughly 24,795 in number of employees claiming about 31% of equities under Drug Manufacturers - Specialty & Generic industry.
RDDAGUGCLHRDDA30.8%GUG12.7%CLH56.5%4OQ10.0%100%
The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.19 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.19.

Dr Reddys Laboratories Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Dr Reddys Laboratories Price Series Summation is a cross summation of Dr Reddys price series and its benchmark/peer.
JavaScript chart by amCharts 3.21.15Dec2025FebJan 27FebFeb 10Feb 17Feb 24Mar12.012.513.013.514.0 2004006008001K 2425262728 12.012.513.013.514.0 Show all
JavaScript chart by amCharts 3.21.15Dr Reddys Laboratories Volume Dr Reddys Laboratories Closing Prices AGNC Investment Corp Closing Prices - Benchmark Dr Reddys Laboratories Price Series Summation

Dr Reddys Notable Stakeholders

A Dr Reddys stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Dr Reddys often face trade-offs trying to please all of them. Dr Reddys' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Dr Reddys' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Parag AgarwalCFO CouncilProfile
Sanjay BTechGlobal VPProfile
Erez MBACEO CouncilProfile
Gunupati BEMD CoChairmanProfile
MS BTechChairman CouncilProfile
MBA MBACEO CouncilProfile
Deepak MBACEO CouncilProfile

About Dr Reddys Management Performance

The success or failure of an entity such as Dr Reddys Laboratories often depends on how effective the management is. Dr Reddys management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of RDDA management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the RDDA management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. DR REDDYS operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 21966 people.

Dr Reddys Workforce Analysis

Traditionally, organizations such as Dr Reddys use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Dr Reddys within its industry.

Dr Reddys Manpower Efficiency

Return on Dr Reddys Manpower

Revenue Per Employee8.6M
Revenue Per Executive30.6B
Net Income Per Employee950.5K
Net Income Per Executive3.4B

Complementary Tools for RDDA Stock analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Content Syndication
Quickly integrate customizable finance content to your own investment portal